HUTCHMED (China) Limited
HCM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2 | $3 | $3 | $6 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $2 | $3 | $2 | $5 |
| Revenue | $1 | $1 | $0 | $0 |
| % Growth | -24.8% | 96.5% | 19.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 44.6% | 54.1% | 27% | 27.5% |
| EBITDA | $0 | $0 | -$0 | -$0 |
| % Margin | 2.2% | 8% | -94.1% | -58.4% |
| Net Income | $0 | $0 | -$0 | -$0 |
| % Margin | 6% | 12% | -84.6% | -54.7% |
| EPS Diluted | 0.22 | 0.6 | -2.15 | -1.25 |
| % Growth | -63.3% | 127.9% | -72% | – |
| Operating Cash Flow | $0 | $0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $0 | -$0 | -$0 |